Merck KGaA Weighs Job Cuts at Electronics Division on Market Downturn
By Helena Smolak
Germany's Merck KGaA is contemplating job cuts within its electronics division as part of a cost-saving initiative prompted by a market downturn that is lasting longer than the industry expected.
The German pharmaceutical and chemical conglomerate said Monday that talks with the works council and employee representatives are in progress.
Merck is seeking to increase efficiencies during an electronics downturn, and while it aims to offer internal job placements, can't rule out personnel cuts, a spokesperson said.
The news was initially reported by German newspaper Frankfurter Allgemeine, which indicatedMerck was targeting cutting costs by 60 million euros to 90 million euros ($64.4 million-$96.6 million) in 2024.
Layoffs at Merck's headquarters in Darmstadt are ruled out by an employment guarantee until the end of 2025, the company said.
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
November 06, 2023 06:05 ET (11:05 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: Tech Stocks Lead Ahead of Nvidia Earnings
-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing